ASX - Delayed Quote AUD

Medical Developments International Limited (MVP.AX)

0.5400 -0.0200 (-3.57%)
At close: April 26 at 4:10 PM GMT+10
Key Events
Loading Chart for MVP.AX
DELL
  • Previous Close 0.5600
  • Open 0.5500
  • Bid 0.5400 x 151800
  • Ask 0.5350 x 237200
  • Day's Range 0.5400 - 0.5650
  • 52 Week Range 0.5400 - 1.8000
  • Volume 74,207
  • Avg. Volume 175,432
  • Market Cap (intraday) 46.605M
  • Beta (5Y Monthly) 1.61
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2300
  • Earnings Date Feb 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 5, 2020
  • 1y Target Est --

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

medicaldev.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: MVP.AX

Performance Overview: MVP.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MVP.AX
28.95%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

MVP.AX
46.80%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

MVP.AX
90.42%
S&P/ASX 200 [XJO]
7.53%

5-Year Return

MVP.AX
90.29%
S&P/ASX 200 [XJO]
18.64%

Compare To: MVP.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MVP.AX

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    46.60M

  • Enterprise Value

    33.33M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.40

  • Price/Book (mrq)

    0.62

  • Enterprise Value/Revenue

    1.00

  • Enterprise Value/EBITDA

    -1.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -57.27%

  • Return on Assets (ttm)

    -13.86%

  • Return on Equity (ttm)

    -23.42%

  • Revenue (ttm)

    33.55M

  • Net Income Avi to Common (ttm)

    -19.21M

  • Diluted EPS (ttm)

    -0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.7M

  • Total Debt/Equity (mrq)

    3.20%

  • Levered Free Cash Flow (ttm)

    -12.79M

Research Analysis: MVP.AX

Analyst Price Targets

 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: MVP.AX

People Also Watch